Deerfield Management Company »

Hci shares owned by Deerfield Management Company

Quarter-by-quarter ownership of Hci (HCI) shares owned by Deerfield Management Company from 13F filings

Historical chart of Deerfield Management Company investment in Hci

Tip: Access up to 7 years of quarterly data

All positions including Hci held by Deerfield Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Hci by Deerfield Management Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $356k 4.1k 87.40

More positions owned by Deerfield Management Company

Nuvalent Inc-a (NUVL)
Glaukos Corp Note 2.750% 6/1 (Principal)
Viatris (VTRS)
Invitae Corp Debt 4.500% 3/1 (Principal)
Natera Note 2.250% 5/0 (Principal)
Catalyst Pharmaceutical Partners (CPRX)
Centene Corporation (CNC)
Brookdale Sr Living Note 2.000%10/1 (Principal)
Insmed Note 1.750% 1/1 (Principal)
Neurocrine Biosciences (NBIX)
Accolade Note 0.500% 4/0 (Principal)
Oscar Health Cl A (OSCR)
Owens & Minor (OMI)
Adapthealth Corp Common Stock (AHCO)
Springworks Therapeutics (SWTX)

View all positions for Deerfield Management Company

Top funds holding Hci

Vanguard Group
Dimensional Fund Advisors
Shellback Capital
Millennium Management
Daniel D. Thurber
Philadelphia Financial Management of San Francisco
Park West Asset Management
Bank of America Corporation
Essex Investment Management
Citadel Advisors
Bernzott Capital Advisors
Alyeska Investment Group
Creative Planning
D. E. Shaw & Co
Assenagon Asset Management

View all funds holding Hci